On the other hand, further studies indicated that METTL3 can promote the progression of GBM by regulating epithelial–mesenchymal transition and vascular patterns, RNA editing, and mRNA decay, to accelerate the cell cycle or enhance the resistance to radiotherapy and chemotherapy, by promoting DNA repair [72,73,125]. This evidence concerns the gene METTL3 and glioblastoma.